Developer docs
API playgroundTry for free, no card

Search company profiles

Cresco Capital Partners

Full company profile

uuid00021th

Namestring
Cresco Capital Partners
Legal namestring
Entourage Effect Capital, LLC
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Cresco Capital Partners, operating today as Entourage Effect Capital (EEC), is a Dallas-based private equity investment firm founded in 2014 and reorganized under its current name in 2022. The firm invests exclusively in the cannabis sector, deploying capital into companies across cultivation, manufacturing, distribution, and retail with the stated thesis of scaling portfolio companies ahead of anticipated federal legalization. Over 9+ years it has deployed more than $140M across 60+ portfolio companies through Fund I, Fund II, and the currently active Fund III, and operates a wholly-owned Arcview Ventures Seed Fund that provides an early-stage allocation alongside the growth-stage focus of the main fund.

The firm's revenue model is that of a conventional closed-end private equity manager: it charges management fees (typically recurring on committed or invested capital) to its limited partners — institutional investors and family offices — and earns carried interest on successful portfolio exits. Its go-to-market approach is relationship-driven rather than technology-mediated: it sources deals through extensive networks both inside and outside the cannabis industry, leverages proprietary diligence refined across multiple expansion cycles, and adds value post-investment through dedicated portfolio managers, facilitation of inter-portfolio M&A, and shareholder activism at publicly traded cannabis companies. No proprietary technology platform, software product, app, or AI/ML capability is disclosed; competitive differentiation is built on regulatory expertise, sector track record, and operating relationships.

The customer base is bifurcated: limited partners (institutional investors and family offices) provide the capital that generates fee revenue, while 60+ cannabis operating companies are the portfolio recipients of that capital and the source of carried interest. Headcount is reported at 1-10 employees, consistent with a lean general-partner structure, and the firm has not disclosed revenue, AUM growth rates, or detailed ownership. Founded by Andrew Sturner, EEC is led by managing partners Sturner, Dov Szapiro, and Matt Hawkins, with managing directors Codie Sanchez and Tiffany Liff and vice president Matt Bryant.

Short descriptiontext

Cresco Capital Partners (operating as Entourage Effect Capital) is a Dallas-based private equity firm founded in 2014 that invests exclusively in cannabis companies across cultivation, manufacturing, distribution, and retail, deploying capital from institutional LPs and family offices.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDallas, United States
HQ citystring
Dallas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
cannabis private equity, venture capital funds, cannabis investment, portfolio management, alternative asset management
Industry1 code
1Venture Capital Fund-of-Funds / Multi-Manager Platforms
CodeFSANAAAJPrimaryYes
NAICS code1 code
  • All Other Financial Investment Activities52399
SIC code1 code
  • Investors, Nec6799
Product category
Cannabis Private Equity
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Fund Management Fees
TypeSubscription Recurring
Description

Investment management firm generating revenue through fund management fees from institutional investors deploying capital into cannabis companies across Fund I, Fund II, and currently Fund III.

entourageeffect.com
2Carried Interest (Performance Fees)
TypeSubscription Recurring
Description

Receives carried interest from successful portfolio company exits and liquidity events, aligning fund manager incentives with investor returns.

entourageeffect.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Cresco Capital Partners, now operating as Entourage Effect Capital, is a private equity and venture capital firm that deploys dedicated cannabis-focused investment funds into early-stage and growth-stage cannabis and hemp companies. Founded in 2014 and rebranded in 2022, the firm currently manages Fund III and operates Arcview Ventures Seed Fund as a wholly-owned subsidiary, having deployed over $140 million across more than 60 portfolio companies.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Entourage Effect Capital (EEC), formerly Cresco Capital Partners, is a cannabis-focused investment firm operating as a platform with multiple investment products. The core offering is Fund III, a growth-stage investment fund currently deploying capital into cannabis companies positioned to scale ahead of federal legalization. This is supplemented by Arcview Ventures Seed Fund, a wholly-owned early-stage allocation vehicle that provides seed-stage investment capabilities within the broader EEC platform. The firm has deployed over $140M across 60+ portfolio companies over 9+ years of cannabis investing.

Product and service2 records
1Fund III (Cresco Capital Partners)
CategoryInvestment Fund
2Arcview Ventures Seed Fund
CategorySeed Investment Fund
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Multi-fund cannabis-focused private equity firm with growth-stage and later-stage investment strategy. Highly comparable as a direct competitor for institutional capital and cannabis deal flow, with a similar vertically-integrated operating-partner approach.

TypeDirect peer
Description

Cannabis-focused venture capital firm making early and growth-stage investments across the cannabis value chain. Direct peer given shared cannabis-only mandate, multi-stage investment approach, and reliance on sector expertise as a primary differentiator.

TypeDirect peer
Description

Earlier cannabis-focused private equity firm with portfolio across cultivation, retail, and ancillary services. Direct peer that pioneered cannabis PE and shares EEC's thesis of building operators ahead of federal reform.

TypeDirect peer
Description

Cannabis-focused investment platform spanning private equity, credit, and operating support. Direct peer competing for similar institutional LPs and cannabis operating companies, with overlapping growth-stage and special situations focus.

TypeDirect peer
Description

Alternative investment manager deploying structured capital and equity into cannabis operators. Comparable as a cannabis-specialist GP raising multi-vintage vehicles and competing for similar growth-stage deal flow.

TypeDirect peer
Description

Cannabis-focused seed and early-stage venture firm. Direct peer to EEC's Arcview Ventures Seed Fund allocation given shared focus on seed-stage cannabis investing and similar LP base.

TypeDirect peer
Description

Long-standing cannabis-focused fund manager with publicly traded and private cannabis securities strategies. Comparable as a sector specialist with multi-vehicle structure and deep cannabis investing history.

TypeEmerging player
Description

Originally a cannabis-focused investment platform affiliated with Canopy Growth, with strategy of equity investments and strategic support across cannabis operators. Comparable as a cannabis-specialist investor with operating-partner orientation, though strategic direction has shifted under new ownership.

TypeRegional player
Description

Canadian-based cannabis-focused merchant bank and advisory firm with co-investment and principal capital deployment. Comparable as a sector-specialist capital provider, though primarily Canada-weighted and more advisory than fund-led.

TypeOthers
Description

Public cannabis operator with strategic investment activity that intersects with PE/VC deployment in the sector. Related ecosystem participant; not a direct fund manager peer but reflects the types of portfolio companies and exit counterparties EEC's strategy targets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment8 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cresco Capital Partners

Cannabis Private Equityentourageeffectcapital.com

Cresco Capital Partners (operating as Entourage Effect Capital) is a Dallas-based private equity firm founded in 2014 that invests exclusively in cannabis companies across cultivation, manufacturing, distribution, and retail, deploying capital from institutional LPs and family offices.

What Cresco Capital Partners does

Cresco Capital Partners, operating today as Entourage Effect Capital (EEC), is a Dallas-based private equity investment firm founded in 2014 and reorganized under its current name in 2022. The firm invests exclusively in the cannabis sector, deploying capital into companies across cultivation, manufacturing, distribution, and retail with the stated thesis of scaling portfolio companies ahead of anticipated federal legalization. Over 9+ years it has deployed more than $140M across 60+ portfolio companies through Fund I, Fund II, and the currently active Fund III, and operates a wholly-owned Arcview Ventures Seed Fund that provides an early-stage allocation alongside the growth-stage focus of the main fund.

The firm's revenue model is that of a conventional closed-end private equity manager: it charges management fees (typically recurring on committed or invested capital) to its limited partners — institutional investors and family offices — and earns carried interest on successful portfolio exits. Its go-to-market approach is relationship-driven rather than technology-mediated: it sources deals through extensive networks both inside and outside the cannabis industry, leverages proprietary diligence refined across multiple expansion cycles, and adds value post-investment through dedicated portfolio managers, facilitation of inter-portfolio M&A, and shareholder activism at publicly traded cannabis companies. No proprietary technology platform, software product, app, or AI/ML capability is disclosed; competitive differentiation is built on regulatory expertise, sector track record, and operating relationships.

The customer base is bifurcated: limited partners (institutional investors and family offices) provide the capital that generates fee revenue, while 60+ cannabis operating companies are the portfolio recipients of that capital and the source of carried interest. Headcount is reported at 1-10 employees, consistent with a lean general-partner structure, and the firm has not disclosed revenue, AUM growth rates, or detailed ownership. Founded by Andrew Sturner, EEC is led by managing partners Sturner, Dov Szapiro, and Matt Hawkins, with managing directors Codie Sanchez and Tiffany Liff and vice president Matt Bryant.

Cresco Capital Partners firmographics

Firmographics
Name
Cresco Capital Partners
Legal name
Entourage Effect Capital, LLC
Website
https://entourageeffectcapital.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
Cresco Capital Partners (operating as Entourage Effect Capital) is a Dallas-based private equity firm founded in 2014 that invests exclusively in cannabis companies across cultivation, manufacturing, distribution, and retail, deploying capital from institutional LPs and family offices.
Ownership category
akta.pro rank

Cresco Capital Partners industry classification

Industry
Product category
Cannabis Private Equity
NAICS
All Other Financial Investment Activities (52399)
SIC
Investors, Nec (6799)
akta.pro primary industry
Venture Capital Fund-of-Funds / Multi-Manager Platforms (FSANAAAJ)

Keywords

  • Cannabis private equity
  • Venture capital funds
  • Cannabis investment
  • Portfolio management
  • Alternative asset management

Where Cresco Capital Partners is headquartered

Location

Headquarters

HQ city
Dallas
HQ country
United States
HQ region
North America

Markets served

Cresco Capital Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Fund Management Fees: Investment management firm generating revenue through fund management fees from institutional investors deploying capital into cannabis companies across Fund I, Fund II, and currently Fund III.
  2. Carried Interest (Performance Fees): Receives carried interest from successful portfolio company exits and liquidity events, aligning fund manager incentives with investor returns.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Cresco Capital Partners product offering

Product offering

Core offering

Cresco Capital Partners, now operating as Entourage Effect Capital, is a private equity and venture capital firm that deploys dedicated cannabis-focused investment funds into early-stage and growth-stage cannabis and hemp companies. Founded in 2014 and rebranded in 2022, the firm currently manages Fund III and operates Arcview Ventures Seed Fund as a wholly-owned subsidiary, having deployed over $140 million across more than 60 portfolio companies.

Product overview

Entourage Effect Capital (EEC), formerly Cresco Capital Partners, is a cannabis-focused investment firm operating as a platform with multiple investment products. The core offering is Fund III, a growth-stage investment fund currently deploying capital into cannabis companies positioned to scale ahead of federal legalization. This is supplemented by Arcview Ventures Seed Fund, a wholly-owned early-stage allocation vehicle that provides seed-stage investment capabilities within the broader EEC platform. The firm has deployed over $140M across 60+ portfolio companies over 9+ years of cannabis investing.

Differentiator

Problem solved

Functional benefit

Products and services

  • Fund III (Cresco Capital Partners)
  • Arcview Ventures Seed Fund

Companies that use Cresco Capital Partners

Customer profile

Segments1 record

Ideal customer profiles2 records

Cresco Capital Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Cresco Capital Partners partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Cresco Capital Partners competitors and assessment

Company assessment

Direct peers

  • Merida Capital Partners: Multi-fund cannabis-focused private equity firm with growth-stage and later-stage investment strategy. Highly comparable as a direct competitor for institutional capital and cannabis deal flow, with a similar vertically-integrated operating-partner approach.
  • Casa Verde Capital: Cannabis-focused venture capital firm making early and growth-stage investments across the cannabis value chain. Direct peer given shared cannabis-only mandate, multi-stage investment approach, and reliance on sector expertise as a primary differentiator.
  • Privateer Holdings: Earlier cannabis-focused private equity firm with portfolio across cultivation, retail, and ancillary services. Direct peer that pioneered cannabis PE and shares EEC's thesis of building operators ahead of federal reform.
  • Gotham Green Partners: Cannabis-focused investment platform spanning private equity, credit, and operating support. Direct peer competing for similar institutional LPs and cannabis operating companies, with overlapping growth-stage and special situations focus.
  • Tuatara Capital: Alternative investment manager deploying structured capital and equity into cannabis operators. Comparable as a cannabis-specialist GP raising multi-vintage vehicles and competing for similar growth-stage deal flow.
  • Phyto Partners: Cannabis-focused seed and early-stage venture firm. Direct peer to EEC's Arcview Ventures Seed Fund allocation given shared focus on seed-stage cannabis investing and similar LP base.
  • Poseidon Asset Management: Long-standing cannabis-focused fund manager with publicly traded and private cannabis securities strategies. Comparable as a sector specialist with multi-vehicle structure and deep cannabis investing history.

Emerging players

  • CanopyBev / Canopy Rivers (legacy): Originally a cannabis-focused investment platform affiliated with Canopy Growth, with strategy of equity investments and strategic support across cannabis operators. Comparable as a cannabis-specialist investor with operating-partner orientation, though strategic direction has shifted under new ownership.

Regional players

  • Argyle Capital Corp: Canadian-based cannabis-focused merchant bank and advisory firm with co-investment and principal capital deployment. Comparable as a sector-specialist capital provider, though primarily Canada-weighted and more advisory than fund-led.

Others

  • SLANG Worldwide / cannabis strategic operators: Public cannabis operator with strategic investment activity that intersects with PE/VC deployment in the sector. Related ecosystem participant; not a direct fund manager peer but reflects the types of portfolio companies and exit counterparties EEC's strategy targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Cresco Capital Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cresco Capital Partners leadership team

Management profile

Number of profiles

Profiles6 records

Cresco Capital Partners subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Cresco Capital Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cresco Capital Partners M&A and investment

M&A and investment

M&A

Investments8 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cresco Capital Partners

What does Cresco Capital Partners do?

Cresco Capital Partners, now operating as Entourage Effect Capital, is a private equity and venture capital firm that deploys dedicated cannabis-focused investment funds into early-stage and growth-stage cannabis and hemp companies. Founded in 2014 and rebranded in 2022, the firm currently manages Fund III and operates Arcview Ventures Seed Fund as a wholly-owned subsidiary, having deployed over $140 million across more than 60 portfolio companies.

Is Cresco Capital Partners a public or private company?

Cresco Capital Partners is a private company. It is classified as venture growth investor backed and is currently operating.

When was Cresco Capital Partners founded?

Cresco Capital Partners was founded in 2014. It employs 1 to 10 people.

Where is Cresco Capital Partners based?

Cresco Capital Partners is headquartered in Dallas, United States, in the North America region.

How does Cresco Capital Partners make money?

Two revenue lines are on record. Fund Management Fees are the primary driver. The others are carried Interest (Performance Fees).

Who are Cresco Capital Partners's main competitors?

Direct peers on record are Merida Capital Partners, Casa Verde Capital, Privateer Holdings, Gotham Green Partners, Tuatara Capital, Phyto Partners and Poseidon Asset Management. CanopyBev / Canopy Rivers (legacy) is listed as an emerging player. Argyle Capital Corp is listed as a regional player. SLANG Worldwide / cannabis strategic operators is listed as an others.

Does Cresco Capital Partners have an API?

No public API is recorded for Cresco Capital Partners.

What industry is Cresco Capital Partners in?

Cresco Capital Partners's product category is Cannabis Private Equity. Its primary akta.pro industry code is FSANAAAJ, Venture Capital Fund-of-Funds / Multi-Manager Platforms. Its NAICS code is 52399 and its SIC code is 6799.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireCRESCO CAPITAL PARTNERS II, LLC ANNOUNCES FILING OF EARLY WARNING REPORT REGARDING HARBORSIDE INC.Cresco Capital Partners II, LLC filed an early warning report announcing the acquisition of 14,960,957 subordinate voting shares of Harborside Inc. for US$5.87 million as part of Harborside's repayment of outstanding promissory notes to Urbn Leaf. The transaction increased Cresco's ownership stake in Harborside from approximately 3.6% to 9.3% on a non-diluted basis, with Cresco Parties collectively holding approximately 9.5% non-diluted and 11.8% partially diluted. Cresco stated it has no immediate plans to acquire additional securities but may do so depending on market conditions and other factors.FinSMEsCresco Capital Partners Rebrands as Entourage Effect Capital; Launches FundCresco Capital Partners rebranded as Entourage Effect Capital and launched Fund III with a $150m initial target. The fund will invest in 10-20 cannabis-related companies over five years, bringing total AUM to about $250m. The firm has invested in 32 companies with 11 exits since 2014.PR NewswireCresco Capital Partners Becomes Entourage Effect Capital; Launches Largest Cannabis Venture Fund YetCresco Capital Partners announced the launch of Fund III with an initial target of $150 million, representing its largest fund to date, and simultaneously rebranded to Entourage Effect Capital (EEC). When fully subscribed, the new fund will bring total assets under management to approximately $250 million, up from the firm's current $100 million in AUM since its founding in 2014. The diversified fund will target growth stage companies across the cannabis value chain including science, licensing, retail, consumer goods, and ancillary services, with plans to invest in 10–20 companies over a five-year investment period.FinSMEsPathogenDx Raises $7.5M in Series B FundingPathogenDx, a DNA-based pathogen testing company, raised $7.5 million in Series B funding led by Cresco Capital Partners. The funds will expand its technology into food and agriculture testing and build on its cannabis industry client base. The company's platform can detect up to 50 pathogens in a single test.Pulse 2.0Arcview Secures $7.7 MillionArcview Group raised $7.7 million in Series A financing led by Trivergance Investments and Cresco Capital Partners. The funding will expand its investor network and asset management offerings. New board members include Jerry Stone, Jonathan Washburn, and Codie A. Sanchez.MjbizdailyArcview cannabis firm gets $7.7 million funding and new ownershipCresco Capital Partners and Trivergance led a $7.7 million Series A funding for the acquisition of Arcview Group, an Oakland cannabis investment firm. The deal includes purchasing Arcview stock and capital for growth, with Trivergance's Jerry Stone becoming executive chair. Arcview aims to become 3X to 5X larger.FinSMEsArcview Raises $7.7M in Series A FinancingArcview Group, an Oakland-based cannabis investor network, raised $7.7M in Series A financing led by Trivergance Investments and Cresco Capital Partners. The round joins existing board members, and the funding will accelerate business functions. Arcview has helped over 1,500 investors place more than $260M into 200+ companies.PR NewswireCresco Capital Partners Raises $60M in Oversubscribed Cannabis Private Equity FundCresco Capital Partners, a US private equity firm focused on the legal cannabis market, announced the closing of an oversubscribed $60 million fund (CCP Fund II), surpassing its original $50 million target by nearly twenty percent.FinSMEsCresco Capital Partners Closes Second Cannabis Fund, at $60MCresco Capital Partners closed $60M for its second cannabis fund, deploying about $22M to 15 companies across the supply chain. The firm has raised over $85M across two funds and achieved seven exits, including Acreage and Green Thumb Industries.VC News DailyCellibre Closes an Oversubscribed FinancingCellibre Inc., a San Diego-based cellular agriculture company, announced the close of an oversubscribed financing round with key investors Cresco Capital Partners II, LLC, Flatiron Venture Partners, and Delta Emerald Ventures. The company plans to deploy its organism-agnostic cell-based manufacturing technology initially to revolutionize the production of cannabinoid-based medicines, targeting a market valued at over $100 billion. The funding will support Cellibre's mission to enable sustainable, pharmaceutical-grade cannabinoid production through bio-based manufacturing.